Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Kayz88on Oct 25, 2024 6:26am
135 Views
Post# 36281556

RE:RE:RE:RE:RE:Has Roger learned his lesson?

RE:RE:RE:RE:RE:Has Roger learned his lesson?That's a tough one right? The FDA needs more data, assuming that they told TLT this 60 days after submission. So in September, TLT is scrambling trying to figure out how to even get the data and where to get it. They gave themselves an optimistic timeline of Q1. I mean...6 months to get data should suffice right? But I guess they found out that getting patient data at a much later point in time is much more difficult than expected because the initial process didn't have this requirement. 
.
.
As for Roger being the right person, this is his legacy and his baby. We can only assume that he will do whatever it takes to make it successful (wishful thinking on my end, but it computes logically) 
.
.
So we wait. The info, data, news and everything is trending positively. The stock price is just lagging behind. 
<< Previous
Bullboard Posts
Next >>